A detailed history of Engineers Gate Manager LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 20,274 shares of APLT stock, worth $17,638. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,274
Holding current value
$17,638
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.35 - $8.5 $88,191 - $172,329
20,274 New
20,274 $172,000
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $89,169 - $293,269
39,631 New
39,631 $269,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $41.8M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.